Floatz logo

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT

Plasma Cell Myeloma

University of Birminghamother_biologicalPhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
89/ 100

Competitive context

474 Active assets in the Plasma Cell Myeloma cohort.

Asset / SponsorPhaseRating
Hyaluronidase fihj
Massachusetts General Hospital
Phase 4BBB
Filanesib
PETHEMA Foundation
Phase 2BBB
VINCRISTINE SULFATE
Roswell Park Cancer Institute
Phase 3BBB
CYCLOSPORIN A
Seoul National University Hospital
Phase 3BBB
Epoetin Alfa
Mayo Clinic
Phase 3BB

View all 50 →

Same molecule, other indications

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT is also rated in:

myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
myeloproliferative neoplasmDormant
BB
Indicative ·
70 / 100
View asset →
chronic myeloid leukemiaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →